Track topics on Twitter Track topics that are important to you
BFi OPTiLAS was founded in 1998 by the merger of the BFI IBEXA Group, a wholly owned subsidiary of the Avnet Corporation, and the Optilas Group, a privately owned company. In January 2002 Gamma Optronik AB was acquired in order to expand and enhance the Group's capabilities in the Nordic area.
Our company is one of Europe's largest distributors of specialist products and services catering to the electronics and photonics markets. We employ over 310 people in 12 offices with sales and marketing coverage across all of Western Europe.
Wolverton Mill South
Phone: 44 (0) 1908 326326
Fax: 44 (0) 1908 221110
BFi OPTiLAS was founded in 1998 by the merger of the BFI IBEXA Group, a wholly owned subsidiary of the Avnet Corporation, and the Optilas Group, a privately owned company. In January 2002 Gamma Optron...
We have published hundreds of BFi OPTiLAS news stories on BioPortfolio along with dozens of BFi OPTiLAS Clinical Trials and PubMed Articles about BFi OPTiLAS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BFi OPTiLAS Companies in our database. You can also find out about relevant BFi OPTiLAS Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...